{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T02:06:34Z","timestamp":1778983594303,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,16]]},"DOI":"10.7759\/cureus.108988","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T01:13:20Z","timestamp":1778980400000},"source":"Crossref","is-referenced-by-count":0,"title":["Diffuse Large B-cell Lymphoma Presenting as a Hypermetabolic Mesenteric Root Mass Without Preoperative Imaging Suspicion of Lymphoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Jinglei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100397","article-title":"Fifth edition of the World Health classification of tumors of the hematopoietic and lymphoid tissue: myeloid neoplasms","volume":"37","author":"Loghavi S","year":"2024","unstructured":"Loghavi S, Kanagal-Shamanna R, Khoury JD, Medeiros LJ, Naresh KN, Nejati R, Patnaik MM. Fifth edition of the World Health classification of tumors of the hematopoietic and lymphoid tissue: myeloid neoplasms. Mod Pathol. 2024, 37:100397. 10.1016\/j.modpat.2023.100397","journal-title":"Mod Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans CP","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al.. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004, 103:275-82. 10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald A","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, et al.. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346:1937-47. 10.1056\/NEJMoa012914","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly H","year":"2015","unstructured":"Tilly H, Gomes da Silva M, Vitolo U, et al.. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015, 26:v116-25. 10.1093\/annonc\/mdv304","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier B","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, et al.. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346:235-42. 10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya S","year":"2021","unstructured":"Susanibar-Adaniya S, Barta SK. 2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management. Am J Hematol. 2021, 96:617-29. 10.1002\/ajh.26151","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson BD","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014, 32:3059-68. 10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington SF","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, et al.. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014, 32:3048-58. 10.1200\/JCO.2013.53.5229","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.110890","article-title":"International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers","volume":"54","author":"Biggi A","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, et al.. International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013, 54:683-90. 10.2967\/jnumed.112.110890","journal-title":"J Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma","volume":"23","author":"Sch\u00f6der H","year":"2005","unstructured":"Sch\u00f6der H, Noy A, G\u00f6nen M, et al.. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005, 23:4643-51. 10.1200\/JCO.2005.12.072","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp030","article-title":"High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma","volume":"20","author":"Ngeow JY","year":"2009","unstructured":"Ngeow JY, Quek RH, Ng DC, et al.. High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma. Ann Oncol. 2009, 20:1543-7. 10.1093\/annonc\/mdp030","journal-title":"Ann Oncol"},{"key":"ref13","article-title":"The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors","volume":"45","author":"Gayed I","year":"2004","unstructured":"Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004, 45:17-21.","journal-title":"J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0045-6","article-title":"18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors","volume":"29","author":"Kamiyama Y","year":"2005","unstructured":"Kamiyama Y, Aihara R, Nakabayashi T, et al.. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg. 2005, 29:1429-35. 10.1007\/s00268-005-0045-6","journal-title":"World J Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.074229","article-title":"Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET","volume":"51","author":"Benz MR","year":"2010","unstructured":"Benz MR, Dry SM, Eilber FC, et al.. Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET. J Nucl Med. 2010, 51:1174-81. 10.2967\/jnumed.109.074229","journal-title":"J Nucl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher JW","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, et al.. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008, 49:480-508. 10.2967\/jnumed.107.047787","journal-title":"J Nucl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-288480","article-title":"Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone","volume":"117","author":"Kim SJ","year":"2011","unstructured":"Kim SJ, Kang HJ, Kim JS, et al.. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 2011, 117:1958-65. 10.1182\/blood-2010-06-288480","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt188","article-title":"Bowel perforation in intestinal lymphoma: incidence and clinical features","volume":"24","author":"Vaidya R","year":"2013","unstructured":"Vaidya R, Habermann TM, Donohue JH, et al.. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013, 24:2439-43. 10.1093\/annonc\/mdt188","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001593111","article-title":"Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment","volume":"45","author":"Lee J","year":"2004","unstructured":"Lee J, Kim WS, Kim K, et al.. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004, 45:339-44. 10.1080\/10428190310001593111","journal-title":"Leuk Lymphoma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492268-diffuse-large-b-cell-lymphoma-presenting-as-a-hypermetabolic-mesenteric-root-mass-without-preoperative-imaging-suspicion-of-lymphoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T01:13:21Z","timestamp":1778980401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492268-diffuse-large-b-cell-lymphoma-presenting-as-a-hypermetabolic-mesenteric-root-mass-without-preoperative-imaging-suspicion-of-lymphoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.108988","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}